Stefan Proniuk

Stefan Proniuk has extensive experience in product development and pharmaceutical sciences. Stefan began their career in 1996 as a Research Assistant for Drug Delivery Technologies at the Drug Dynamics Institute, University of Texas at Austin. In 1997, they moved to the University of Arizona as a Research Associate in Pharmaceutical Sciences. In 2001, they joined Cima Labs as a Formulation Scientist. From 2002 to 2008, they worked at Neurocrine Biosciences in various roles, beginning as a Scientist II and eventually becoming a Sr. Manager of Pharmaceutical Technologies. From 2008 to 2017, they were employed at Arno Therapeutics in various roles, beginning as a Director of Product Development and eventually becoming the Chief Development Officer. Since 2017, they have been the Chief Development Officer at Neuraptive Therapeutics.

Stefan Proniuk has a diverse educational background, having attained a Doctorate in Pharmaceutical Sciences from the University of Arizona, an MBA in Entrepreneurship from San Diego State University, a Diplom in Pharmaceutical Chemistry from the University of Applied Sciences in Isny, Germany, a Certificate in Intellectual Property Law from UC San Diego, and Executive Education in Corporate Governance from Columbia Business School.